Targeting RAS-Driven Cancers by AACR

Targeting RAS-Driven Cancers is organized by American Association for Cancer Research (AACR) and will be held from Dec 09 - 12, 2018 at Hilton San Diego Bayfront, San Diego, California, United States of America.

The target audience for this medical event is physicians and health care workers who work with patients who have cancers that are or have a high probability of being driven by a RAS mutation, including but not limited to pancreatic cancer, colon cancer, biliary tract cancer, and malignant melanoma. This CME Conference has been approved for a maximum of 18.00 AMA PRA Category 1 Credits.

Mutations in RAS genes, KRAS in particular, are present in 30% of all cancers. As a result of key therapeutic advances as well as improvements in areas of basic research due to updated technologies, the last 5 years have witnessed an invigoration in the field. Therapeutic discoveries directed at targeting KRAS, as well as effectors in artificial membranes becoming more accessible, have helped KRAS re-emerge as a “druggable” target.

This conference will focus on potentially druggable aspects of KRAS biology, including emergent areas such as systems approaches and immunotherapy. The conference will leverage the substantial gains in recent years in the understanding of proximal targeting of KRAS to provide a comprehensive and in-depth forum, and will include field leaders in all aspects of KRAS biology to allow for direct engagement between industry and academia.

After participating in this CME activity, physicians should be able to:
•  Evaluate models of KRAS-driven cancer biology in the context of utility/application, such as therapeutic development.
•  Interpret the continued challenges to developing clinical strategies for KRAS-driven cancers.
•  Distinguish between presented therapeutic targets in KRAS biology and the possibility of near-term success in applications.
•  Integrate laboratory and clinical observations.
•  Identify and analyze emergent areas in KRAS biology and areas with a continued need for knowledge/technological expansion.

Additional details will be posted as soon as they are available.